Skip to main content
New site added by InVivo for neurospinal scaffold trial

Stanford Medicine has been added by InVivo Therapeutics as a clinical site for the study of its Neuro-Spinal Scaffold, bringing the total number of trial sites to 34. The biodegradable, implantable device is intended to work as a physical substrate for nerve sprouting after acute spinal cord injuries.

Full Story: